About: The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 September 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у вересні 2000 (uk) article scientifique publié en septembre 2000 (fr) artículu científicu espublizáu en setiembre de 2000 (ast) scientific article published on 01 September 2000 (en)
publication date	wds:Q73152513-BDDD4E55-0898-4CDB-ABEB-D14A5F700E3F
publication date	2000-09-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q73152513-C330DBE9-0B1B-47D6-B131-A5C73A7F2967 wds:Q73152513-D1175A8F-2332-4DC8-8406-AA0F38F7FFDF wds:Q73152513-E68C3314-AD26-4033-A209-CF75EE16A8E8 wds:Q73152513-EB163241-B38D-4470-8C17-18815DDA4770 wds:Q73152513-EDACCCB9-451A-4322-95A3-DC00A54116DA
author name string	N J Wareham S Griffin T Lauritzen G Rutten Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen Detected Diabetes in Primary Care
rdfs:label	The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening (en) The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening (nl)
skos:prefLabel	The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening (en) The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening (nl)
name	The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening (en) The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening (nl)
author	wds:Q73152513-11E563E3-DFEF-4310-9A74-1D9F182549BC wds:Q73152513-61FA38ED-5356-4B7D-A0A8-D2CBAF395C5E
author	Knut Borch-Johnsen Bruce H Wolffenbuttel
title	wds:Q73152513-6AB3BAD5-904D-484A-8BD7-E2E0D737E303
title	The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening (en)
page(s)	wds:Q73152513-9F1FD8B4-66E1-4FB0-99C1-37B1DC590703
page(s)	S6-11
instance of	wds:Q73152513-37BDDAE5-B501-4D23-86E6-BA8ADC221E3E
instance of	scholarly article
main subject	wds:Q73152513-A6FFEF8B-9F0B-4207-B097-3024D477F6F7
main subject	type 2 diabetes
PubMed ID	wds:Q73152513-7947B380-9410-44DA-B1E2-6E8123B07C6C
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11063279
PubMed ID	11063279
volume	wds:Q73152513-C5E099DC-0F30-4E34-82EB-5CC6627EF272
volume	24 Suppl 3
DOI	wds:Q73152513-2613F56E-3417-4468-87AF-CC6DD9E82EF2
DOI	http://dx.doi.org/10.1038/SJ.IJO.0801420
DOI	10.1038/SJ.IJO.0801420
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73152513
is cites work of	The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity Non-replication of genome-wide based associations between common variants in INSIG2 and PFKP and obesity in studies of 18,014 Danes Solute carrier family 2 member 1 is involved in the development of nonalcoholic fatty liver disease Effectiveness of a Multicomponent Quality Improvement Strategy to Improve Achievement of Diabetes Care Goals: A Randomized, Controlled Trial Lifting the lid of the "black intervention box" - the systematic development of an action competence programme for people with screen-detected dysglycaemia What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications? SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations No negative effects of a multi-factorial, intensified treatment on self-reported health status, treatment satisfaction, and diabetes-related distress in screen-detected type 2 diabetes patients. The ADDITION-Netherlands study Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial Does early intensive multifactorial treatment reduce total cardiovascular burden in individuals with screen-detected diabetes? Findings from the ADDITION-Europe cluster-randomized trial Whole-exome sequencing of 2,000 Danish individuals and the role of rare coding variants in type 2 diabetes Interventions for enhancing medication adherence Protocol for the ADDITION-Plus study: a randomised controlled trial of an individually-tailored behaviour change intervention among people with recently diagnosed type 2 diabetes under intensive UK general practice care Effect of "motivational interviewing" on quality of care measures in screen detected type 2 diabetes patients: a one-year follow-up of an RCT, ADDITION Denmark Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia What determines the cost-effectiveness of diabetes screening? Combined analysis of 19 common validated type 2 diabetes susceptibility gene variants shows moderate discriminative value and no evidence of gene–gene interaction The ADDITION-Cambridge trial protocol: a cluster -- randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients MTNR1B G24E variant associates With BMI and fasting plasma glucose in the general population in studies of 22,142 Europeans Multifactorial intervention to reduce cardiovascular events in type 2 diabetes A role for coding functional variants in HNF4A in type 2 diabetes susceptibility Prevalence of Sexual Concerns and Sexual Dysfunction among Sexually Active and Inactive Men and Women with Screen-Detected Type 2 Diabetes An education and training course in motivational interviewing influence: GPs' professional behaviour--ADDITION Denmark Natural selection affects multiple aspects of genetic variation at putatively neutral sites across the human genome. Identification of low-frequency and rare sequence variants associated with elevated or reduced risk of type 2 diabetes. Studies of metabolic phenotypic correlates of 15 obesity associated gene variants Impact of polymorphisms in WFS1 on prediabetic phenotypes in a population-based sample of middle-aged people with normal and abnormal glucose regulation Implications of central obesity-related variants in LYPLAL1, NRXN3, MSRA, and TFAP2B on quantitative metabolic traits in adult Danes Impact of rs361072 in the phosphoinositide 3-kinase p110beta gene on whole-body glucose metabolism and subunit protein expression in skeletal muscle Randomised controlled trial of intensive multifactorial treatment for cardiovascular risk in patients with screen-detected type 2 diabetes: 1-year data from the ADDITION Netherlands study Practical aspects of the control of cardiovascular risk in type 2 diabetes mellitus and the metabolic syndrome Screening for type 2 diabetes is feasible, acceptable, but associated with increased short-term anxiety: a randomised controlled trial in British general practice. Selection in Europeans on Fatty Acid Desaturases Associated with Dietary Changes Protocol for ADDITION-PRO: a longitudinal cohort study of the cardiovascular experience of individuals at high risk for diabetes recruited from Danish primary care Effect of intensive multifactorial treatment compared with routine care on aortic stiffness and central blood pressure among individuals with screen-detected type 2 diabetes: the ADDITION-Denmark study Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial Translation, adaptation and validation of the American short form Patient Activation Measure (PAM13) in a Danish version Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study. Effect of early intensive multifactorial therapy compared with routine care on self-reported health status, general well-being, diabetes-specific quality of life and treatment satisfaction in screen-detected type 2 diabetes mellitus patients (ADDITI Adherence to guidelines in people with screen-detected type 2 diabetes, ADDITION, Denmark Detailed investigation of the role of common and low-frequency WFS1 variants in type 2 diabetes risk Variants near MC4R are associated with obesity and influence obesity-related quantitative traits in a population of middle-aged people: studies of 14,940 Danes General practitioners trained in motivational interviewing can positively affect the attitude to behaviour change in people with type 2 diabetes. One year follow-up of an RCT, ADDITION Denmark Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screening Lipid-lowering drugs as primary prevention in general practice: do patients reach guideline goals and continue treatment? ADDITION Denmark Determinants of progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screened population: 3 year follow-up in the ADDITION study, Denmark Prevalence of neuropathy and peripheral arterial disease and the impact of treatment in people with screen-detected type 2 diabetes: the ADDITION-Denmark study General effect on high-risk persons when general practitioners are trained in intensive treatment of type 2 diabetes Population-based stepwise screening for unrecognised Type 2 diabetes is ineffective in general practice despite reliable algorithms Progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screening programme in general practice: the ADDITION Study, Denmark. Bioinformatics-driven identification and examination of candidate genes for non-alcoholic fatty liver disease Mendelian randomization study of B-type natriuretic peptide and type 2 diabetes: evidence of causal association from population studies Studies of a genetic variant in HK1 in relation to quantitative metabolic traits and to the prevalence of type 2 diabetes Change in cardiovascular risk factors following early diagnosis of type 2 diabetes: a cohort analysis of a cluster-randomised trial

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software